Bill

Bill > S01795


NY S01795

NY S01795
Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors in certain cases.


summary

Introduced
01/13/2025
In Committee
01/07/2026
Crossed Over
Passed
Dead

Introduced Session

2025-2026 General Assembly

Bill Summary

AN ACT to amend the education law, in relation to the substitution of brand name epinephrine auto-injectors with alternate epinephrine autoinjectors for dispensation by pharmacists

AI Summary

This bill allows pharmacists to substitute a brand name epinephrine auto-injector (such as an EpiPen) with an alternate epinephrine auto-injector under specific conditions. These conditions include: the prescriber has not indicated that the specific brand must be dispensed, the alternate auto-injector is less expensive for the purchaser, the pharmacist has advised the patient about the alternate option and obtained their consent, and the pharmacist has provided counseling on how to use the new device. An epinephrine auto-injector is a medical device used to quickly deliver a dose of epinephrine (adrenaline) in emergency situations, typically for people experiencing severe allergic reactions (anaphylaxis). The bill amends the education law to give pharmacists more flexibility in providing potentially more affordable alternatives to patients while ensuring patient safety through consent and counseling requirements. The legislation takes effect immediately upon passage.

Committee Categories

Education

Sponsors (3)

Last Action

REFERRED TO HIGHER EDUCATION (on 01/07/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...